Sign in

CIK 0001160308

  • Non-accelerated filer
  • Smaller reporting company
Ticker
SVRA
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
FY end
Dec 31
Incorporated
DE
Entity type
Operating
EIN
841318182
Phone
+51 285113796
Business address
6836 BEE CAVE ROAD, BUILDING 3, SUITE 201, AUSTIN, TX, 78746
Former names
Mast Therapeutics, Inc., ADVENTRX PHARMACEUTICALS INC, BIOKEYS PHARMACEUTICALS INC
Open-market buys, last 90 days
$0
in 0 filings
Open-market sales, last 90 days
$0
in 0 filings

Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.

Reading 100 more Form 4s from the SEC; this list fills in as they're read.

Date Insider Transaction Shares Price Value Owned after
2017-01-23 Pauls Matthew Director Grant or award · Restricted Stock Units +45,535 45,535
2017-01-20 Greenleaf Peter Director Grant or award · Restricted Stock Units +45,535 45,535
2017-01-20 RAMSAY DAVID A Director Grant or award · Restricted Stock Units +79,962 79,962
2017-01-20 Hood Shana General Counsel & VP Grant or award · Restricted Stock Units +453,556 453,556
2017-01-20 Culley Brian M CEO and Director Grant or award · Restricted Stock Units +2,368,194 2,368,194
2017-01-20 Parsley Edwin L. Chief Medical Officer & SVP Grant or award · Restricted Stock Units +894,572 894,572
2017-01-20 DITTRICH HOWARD Director Grant or award · Restricted Stock Units +63,933 63,933
2017-01-20 Roberts Brandi Chief Financial Officer & SVP Grant or award · Restricted Stock Units +889,926 889,926
2016-06-15 RAMSAY DAVID A Director Grant or award · Stock Option (Right to Buy) +79,551 79,551
2016-06-15 Pauls Matthew Director Grant or award · Stock Option (Right to Buy) +79,551 79,551

Page 20 of 20 · 390 trades